Cargando…
Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor
Impaired healing is common in wounds infected with the major human pathogen Staphylococcus aureus, although the underlying mechanisms are poorly understood. Here, we show that S. aureus lipoteichoic acid (LTA) inhibits platelet aggregation caused by physiological agonists and S. aureus and reduced p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836464/ https://www.ncbi.nlm.nih.gov/pubmed/23911710 http://dx.doi.org/10.1093/infdis/jit398 |
_version_ | 1782292305684725760 |
---|---|
author | Waller, Amie K. Sage, Tanya Kumar, Christopher Carr, Thomas Gibbins, Jonathan M. Clarke, Simon R. |
author_facet | Waller, Amie K. Sage, Tanya Kumar, Christopher Carr, Thomas Gibbins, Jonathan M. Clarke, Simon R. |
author_sort | Waller, Amie K. |
collection | PubMed |
description | Impaired healing is common in wounds infected with the major human pathogen Staphylococcus aureus, although the underlying mechanisms are poorly understood. Here, we show that S. aureus lipoteichoic acid (LTA) inhibits platelet aggregation caused by physiological agonists and S. aureus and reduced platelet thrombus formation in vitro. The presence of D-alanine on LTA is necessary for the full inhibitory effect. Inhibition of aggregation was blocked using a monoclonal anti-platelet activating factor receptor (PafR) antibody and Ginkgolide B, a well-defined PafR antagonist, demonstrating that the LTA inhibitory signal occurs via PafR. Using a cyclic AMP (cAMP) assay and a Western blot for phosphorylated VASP, we determined that cAMP levels increase upon platelet incubation with LTA, an effect which inhibits platelet activation. This was blocked when platelets were preincubated with Ginkgolide B. Furthermore, LTA reduced hemostasis in a mouse tail-bleed assay. |
format | Online Article Text |
id | pubmed-3836464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38364642013-11-22 Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor Waller, Amie K. Sage, Tanya Kumar, Christopher Carr, Thomas Gibbins, Jonathan M. Clarke, Simon R. J Infect Dis Major Articles and Brief Reports Impaired healing is common in wounds infected with the major human pathogen Staphylococcus aureus, although the underlying mechanisms are poorly understood. Here, we show that S. aureus lipoteichoic acid (LTA) inhibits platelet aggregation caused by physiological agonists and S. aureus and reduced platelet thrombus formation in vitro. The presence of D-alanine on LTA is necessary for the full inhibitory effect. Inhibition of aggregation was blocked using a monoclonal anti-platelet activating factor receptor (PafR) antibody and Ginkgolide B, a well-defined PafR antagonist, demonstrating that the LTA inhibitory signal occurs via PafR. Using a cyclic AMP (cAMP) assay and a Western blot for phosphorylated VASP, we determined that cAMP levels increase upon platelet incubation with LTA, an effect which inhibits platelet activation. This was blocked when platelets were preincubated with Ginkgolide B. Furthermore, LTA reduced hemostasis in a mouse tail-bleed assay. Oxford University Press 2013-12-15 2013-08-02 /pmc/articles/PMC3836464/ /pubmed/23911710 http://dx.doi.org/10.1093/infdis/jit398 Text en © The Author 2013. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Major Articles and Brief Reports Waller, Amie K. Sage, Tanya Kumar, Christopher Carr, Thomas Gibbins, Jonathan M. Clarke, Simon R. Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor |
title | Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor |
title_full | Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor |
title_fullStr | Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor |
title_full_unstemmed | Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor |
title_short | Staphylococcus aureus Lipoteichoic Acid Inhibits Platelet Activation and Thrombus Formation via the Paf Receptor |
title_sort | staphylococcus aureus lipoteichoic acid inhibits platelet activation and thrombus formation via the paf receptor |
topic | Major Articles and Brief Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836464/ https://www.ncbi.nlm.nih.gov/pubmed/23911710 http://dx.doi.org/10.1093/infdis/jit398 |
work_keys_str_mv | AT walleramiek staphylococcusaureuslipoteichoicacidinhibitsplateletactivationandthrombusformationviathepafreceptor AT sagetanya staphylococcusaureuslipoteichoicacidinhibitsplateletactivationandthrombusformationviathepafreceptor AT kumarchristopher staphylococcusaureuslipoteichoicacidinhibitsplateletactivationandthrombusformationviathepafreceptor AT carrthomas staphylococcusaureuslipoteichoicacidinhibitsplateletactivationandthrombusformationviathepafreceptor AT gibbinsjonathanm staphylococcusaureuslipoteichoicacidinhibitsplateletactivationandthrombusformationviathepafreceptor AT clarkesimonr staphylococcusaureuslipoteichoicacidinhibitsplateletactivationandthrombusformationviathepafreceptor |